Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
6.00
-0.01 (-0.17%)
At close: Dec 23, 2025, 4:00 PM EST
5.99
-0.01 (-0.17%)
After-hours: Dec 23, 2025, 5:26 PM EST
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $834.75 million as of December 23, 2025. Its market cap has decreased by -23.95% in one year.
Market Cap
834.75M
Enterprise Value
418.67M
1-Year Change
-23.95%
Ranking
Category
Stock Price
$6.00
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $834.75M, a decrease of -45.57%. That is a compound annual growth rate of -9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 836.14M | -17.28% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |